| 1 |
35163378 | Current Knowledge about the New Drug Firibastat in Arterial Hypertension. | 2022 Jan 27 |
1 |
| 2 |
33520782 | Firibastat, the first-in-class brain aminopeptidase a inhibitor, in the management of hypertension: A review of clinical trials. | 2021 Jan-Mar |
2 |
| 3 |
33683322 | Brain ACE2 activation following brain aminopeptidase A blockade by firibastat in salt-dependent hypertension. | 2021 Mar 26 |
1 |
| 4 |
33881611 | Aminopeptidase A contributes to biochemical, anatomical and cognitive defects in Alzheimer's disease (AD) mouse model and is increased at early stage in sporadic AD brain. | 2021 Jun |
1 |
| 5 |
32955085 | Structural insight into the catalytic mechanism and inhibitor binding of aminopeptidase A. | 2020 Nov 13 |
2 |
| 6 |
30882604 | A pilot double-blind randomized placebo-controlled crossover pharmacodynamic study of the centrally active aminopeptidase A inhibitor, firibastat, in hypertension. | 2019 Aug |
2 |
| 7 |
31014072 | Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins. | 2019 Jul 9 |
1 |
| 8 |
24337978 | Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase a inhibitor prodrug. | 2014 Apr |
1 |
| 9 |
25474003 | [Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension]. | 2014 |
1 |
| 10 |
21763394 | The role of the brain renin-angiotensin system in hypertension: implications for new treatment. | 2011 Oct |
1 |
| 11 |
18175217 | Aminopeptidase A inhibitors as centrally acting antihypertensive agents. | 2008 Sep |
1 |
| 12 |
15748538 | Role of angiotensin III in hypertension. | 2005 Apr |
1 |